This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamamoto, M. Articles by Kiyono, H. Search for Related Content PubMed PubMed Citation Articles by Yamamoto, M. Articles by Kiyono, H. Pubmed/NCBI databases Substance via MeSH

 Previous Article  |  Next Article 

Infect. Immun., 02 1997, 640-644, Vol 65, No. 2
Copyright © 1997, American Society for Microbiology

Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection

M Yamamoto, LS McDaniel, K Kawabata, DE Briles, RJ Jackson, JR McGhee and H Kiyono
Department of Oral Biology, The University of Alabama at Birmingham, 35294-2170, USA.

Streptococcus pneumoniae is a major respiratory mucosal pathogen affecting infants and children. Although a polysaccharide-based vaccine has been useful in adult populations, it does not elicit protective immunity in infants and young children. Pneumococcal surface protein A (PspA) is a highly immunogenic surface protein produced by all strains of Streptococcus pneumoniae. Previous studies have shown that systemic immunization of mice with PspA can elicit protective immunity against fatal pneumococcal infection. In this study, we demonstrated that oral immunization with PspA could elicit protective immune responses against pneumococcal infection. When mice were orally immunized with PspA alone, low levels of PspA-specific immunoglobulin G (IgG) responses were induced in serum; none was induced in secretion. On the other hand, when PspA was given orally with the mucosal adjuvant cholera toxin (CT), significant levels of IgG and IgA anti-PspA responses were induced in serum. The major IgG subclass was IgG1, followed by IgG2b, a profile of antibody response supported by Th2-type cells. In addition, all mice orally immunized with PspA and CT were protected from the lethal challenge with capsular serotype 3 S. pneumoniae A66. These results suggested that an oral PspA vaccine may be a useful means of preventing pneumococcal disease.

This article has been cited by other articles:

• Jomaa, M., Yuste, J., Paton, J. C., Jones, C., Dougan, G., Brown, J. S. (2005). Antibodies to the Iron Uptake ABC Transporter Lipoproteins PiaA and PiuA Promote Opsonophagocytosis of Streptococcus pneumoniae. Infect. Immun. 73: 6852-6859 [Abstract] [Full Text]  
• Shaper, M., Hollingshead, S. K., Benjamin, W. H. Jr., Briles, D. E. (2004). PspA Protects Streptococcus pneumoniae from Killing by Apolactoferrin, and Antibody to PspA Enhances Killing of Pneumococci by Apolactoferrin. Infect. Immun. 72: 5031-5040 [Abstract] [Full Text]  
• Strand, T. A., Hollingshead, S. K., Julshamn, K., Briles, D. E., Blomberg, B., Sommerfelt, H. (2003). Effects of Zinc Deficiency and Pneumococcal Surface Protein A Immunization on Zinc Status and the Risk of Severe Infection in Mice. Infect. Immun. 71: 2009-2013 [Abstract] [Full Text]  
• Balachandran, P., Brooks-Walter, A., Virolainen-Julkunen, A., Hollingshead, S. K., Briles, D. E. (2002). Role of Pneumococcal Surface Protein C in Nasopharyngeal Carriage and Pneumonia and Its Ability To Elicit Protection against Carriage of Streptococcus pneumoniae. Infect. Immun. 70: 2526-2534 [Abstract] [Full Text]  
• Kang, H. Y., Srinivasan, J., Curtiss, R. III (2002). Immune Responses to Recombinant Pneumococcal PspA Antigen Delivered by Live Attenuated Salmonella enterica Serovar Typhimurium Vaccine. Infect. Immun. 70: 1739-1749 [Abstract] [Full Text]  
• Samukawa, T., Yamanaka, N., Hollingshead, S., Klingman, K., Faden, H. (2000). Immune Responses to Specific Antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the Respiratory Tract. Infect. Immun. 68: 1569-1573 [Abstract] [Full Text]  
• Kozarov, E., Miyashita, N., Burks, J., Cerveny, K., Brown, T. A., McArthur, W. P., Progulske-Fox, A. (2000). Expression and Immunogenicity of Hemagglutinin A from Porphyromonas gingivalis in an Avirulent Salmonella enterica Serovar Typhimurium Vaccine Strain. Infect. Immun. 68: 732-739 [Abstract] [Full Text]  
• Briles, D. E., Ades, E., Paton, J. C., Sampson, J. S., Carlone, G. M., Huebner, R. C., Virolainen, A., Swiatlo, E., Hollingshead, S. K. (2000). Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage of Streptococcus pneumoniae. Infect. Immun. 68: 796-800 [Abstract] [Full Text]  
• Yamamoto, M., Kiyono, H., Yamamoto, S., Batanero, E., Kweon, M.-N., Otake, S., Azuma, M., Takeda, Y., McGhee, J. R. (1999). Direct Effects on Antigen-Presenting Cells and T Lymphocytes Explain the Adjuvanticity of a Nontoxic Cholera Toxin Mutant. J. Immunol. 162: 7015-7021 [Abstract] [Full Text]  
• Yamamoto, M., Briles, D. E., Yamamoto, S., Ohmura, M., Kiyono, H., McGhee, J. R. (1998). A Nontoxic Adjuvant for Mucosal Immunity to Pneumococcal Surface Protein A. J. Immunol. 161: 4115-4121 [Abstract] [Full Text]  
• Nayak, A. R., Tinge, S. A., Tart, R. C., McDaniel, L. S., Briles, D. E., Curtiss, R. III (1998). A Live Recombinant Avirulent Oral Salmonella Vaccine Expressing Pneumococcal Surface Protein A Induces Protective Responses against Streptococcus pneumoniae. Infect. Immun. 66: 3744-3751 [Abstract] [Full Text]